All In Biotech

Free tool

FAERS Monitor: Lysteda

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022430 or its brand name (Lysteda, Tranexamic Acid). Reports on generic versions are filed under their own applications.

Reports

8,563

Serious

7,950

93% of reports

Hospitalization

3,859

Death reported

1,245

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective641
  • off label use632
  • pyrexia347
  • hypotension322
  • nausea322
  • diarrhoea308
  • haemorrhage296
  • vomiting290
  • dyspnoea283
  • pneumonia265
  • febrile neutropenia246
  • anaphylactic reaction230
  • headache229
  • anaemia222
  • seizure217

Reports by year received

View as table
YearReports
200437
200533
200639
200731
200865
200962
2010144
2011181
2012164
2013161
2014173
2015263
2016296
2017385
2018445
2019632
2020579
2021806
2022843
2023675
2024917
2025997
2026635

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,596 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
anaphylactic reactionSignal23010.39.01,911
febrile neutropeniaSignal2469.18.11,774
haemorrhageSignal2967.06.21,512
seizureSignal2174.64.1614
hypotensionSignal3223.93.5711
anaemiaSignal2222.92.5269
pyrexiaSignal3472.52.2305
pneumoniaSignal2652.01.8136
off label use6321.81.6221
vomiting2901.51.451
dyspnoea2831.21.112
drug ineffective6411.21.121
diarrhoea3081.21.18
nausea3221.00.90
headache2290.90.83

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.